Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

HELX vs HRTS overlap: 16% of top holdings shared

Bottom line

How much do HELX and HRTS overlap?

16% of their top holdings overlap by weight. 5 securities appear in both funds' top 25, making up 13.7% of HELX's assets and 22.7% of HRTS's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

HELXHRTS
Weight overlap (top 25)16%
Shared holdings5
Weight in shared holdings13.7%22.7%
Total positions6345
Expense ratio0.5%0.75%
Holdings as ofJun 30, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Holdings HELX and HRTS have in common

Holding% of HELX% of HRTSOverlap
Bridgebio Pharma Inc BBIO3.50%2.59%2.59%
Eli Lilly & Company LLY2.95%11.52%2.95%
Vertex Pharmaceuticals Inc VRTX2.75%2.93%2.75%
Astrazeneca Plc AZN2.70%4.00%2.70%
Regeneron Pharmaceuticals Inc REGN1.80%1.67%1.67%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in HELX

  1. Guardant Health Inc — 9.09%
  2. Natera Inc — 7.46%
  3. Krystal Biotech Inc — 6.33%
  4. Ligand Pharmaceuticals Inc — 4.62%
  5. Adaptive Biotechnologies Corp — 3.99%
  6. United Therapeutics Corp — 3.51%
  7. Twist Bioscience Corp — 2.85%
  8. Travere Therapeutics Inc — 2.59%
  9. Insmed Inc — 2.44%
  10. Samsung Biologics Co Ltd — 2.26%
  11. Corteva Inc — 2.25%
  12. Medpace Holdings Inc — 2.15%
  13. Alnylam Pharmaceuticals Inc — 1.96%
  14. Tempus Ai Inc — 1.95%
  15. Ionis Pharmaceuticals Inc — 1.91%

Only in HRTS

  1. UnitedHealth Group Inc — 5.24%
  2. Novo Nordisk A/S — 5.24%
  3. Roche Holding AG — 4.50%
  4. Merck & Co Inc — 4.27%
  5. Thermo Fisher Scientific Inc — 3.97%
  6. Johnson & Johnson — 3.59%
  7. Gilead Sciences Inc — 3.43%
  8. Novartis AG — 3.38%
  9. Revolution Medicines Inc — 3.33%
  10. Danaher Corp — 2.66%
  11. Abbott Laboratories — 2.61%
  12. Cytokinetics Inc — 2.52%
  13. AbbVie Inc — 2.40%
  14. Bristol-Myers Squibb Co — 2.09%
  15. Teva Pharmaceutical Industries — 2.06%

Asset mix

Asset typeHELXHRTS
Stocks97.9%99.2%
Preferred stock0.9%—
Cash & short-term funds—0.7%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Country mix

CountryHELXHRTS
US86.6%74.9%
CH1.2%7.9%
DK—7.0%
GB3.0%4.0%
KR2.6%—
DE2.2%—
NL2.1%—
IL—2.1%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Check another pair

FAQ

How much do HELX and HRTS overlap?
About 16% by weight. 5 securities appear in both funds' top 25 holdings; they make up 13.7% of HELX's assets and 22.7% of HRTS's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do HELX and HRTS have in common?
The largest shared holdings are Eli Lilly & Company, Vertex Pharmaceuticals Inc, Astrazeneca Plc, Bridgebio Pharma Inc, Regeneron Pharmaceuticals Inc.
Should I own both HELX and HRTS?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, HELX or HRTS?
HELX is broader, with 63 positions versus 45 for HRTS. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.